Jalalon, Wilma A.

HRN: 27-82-57  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2025
RIFAXIMIN 200MG (TAB)
09/24/2025
10/01/2025
PO
200mg
Q12
AGE
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines